Global Key SolutionsGKS
Guidance Documents/Guidance-Document/Current Good Manufacturing Practice for Phase 1 Investigational Drugs: Guidance for Industry

Current Good Manufacturing Practice for Phase 1 Investigational Drugs: Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

July 14, 2008

September 29, 2023

Center for Drug Evaluation and Research

179f8504-7c99-4bec-826e-e67ad9ce1f79

Related Documents

E2E Pharmacovigilance Planning

Guidance DocumentApril 1, 2005Center for Drug Evaluation and Research
View Details →

Quality Systems Approach to Pharmaceutical Current Good Manufacturing Practice Regulations

Guidance DocumentOctober 2, 2006Center for Drug Evaluation and Research
View Details →

Sterile Drug Products Produced by Aseptic Processing — Current Good Manufacturing Practice: Guidance for Industry

Guidance DocumentOctober 4, 2004Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
[email protected]
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.